Anti-resorptive agent related osteonecrosis of the jaw (ARONJ) in urological malignancies: Is the risk different between kidney and prostate cancer patients?

Anti-resorptive agent related osteonecrosis of the jaw (ARONJ) in urological malignancies: Is the risk different between kidney and prostate cancer patients?

Bibliographic Details
Main Authors: Y. Sakai, S Sato, T. Shindo, A. Takahashi, Y. Kunishima, R. Kato, N. Ito, M. Okada, H. Tachiki, K. Taguchi, T. Hirose, H. Hotta, H. Horita, M. Matsukawa, T. Muranaka, K. Nishiyama, A. Miyazaki, K. Hashimoto, T. Tanaka, N. Masumori
Format: Article
Language:English
Published: Elsevier 2020-07-01
Series:European Urology Open Science
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168320333164

Internet

http://www.sciencedirect.com/science/article/pii/S2666168320333164

Similar Items